Latest Funding News

Neuren Pharmaceuticals has initiated the first US investigational site for its pivotal Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, marking a significant milestone in addressing this rare neurodevelopmental disorder.

Tasmea Limited has reported a robust FY25 with a record $600 million order book for FY26, underpinning a confident earnings outlook. The company’s strategic acquisitions and strong organic growth fuel a 32% NPAT increase forecast for FY26.

GDI Property Group reports robust leasing activity with over 32,000sqm leased in FY25, fueling a 20% increase in Funds From Operations. Strategic asset sales and refinancing position the company well for continued growth in a tightening Perth office market.

GDI has reported a strong FY25 with a 22% increase in Property Funds From Operations, robust leasing activity, and significant asset sales, while maintaining its distribution guidance for FY26.

GDI Property Group has reported a strong turnaround in FY25, posting a $35.6 million net profit and a 20% increase in Funds From Operations, while maintaining its distribution at 5 cents per security.

Horizon Gold has successfully closed its $7 million entitlement offer with an 86% take-up, raising nearly $6 million and planning to place the remaining shortfall shares soon.

Rubicon Water reported a record FY25 revenue of A$69.1 million, driven by strong growth in the US and Rest of World markets, while reducing its net loss and building a robust project pipeline for FY26.

Rubicon Water’s FY25 results reveal strong global revenue growth led by the US and EMEA, alongside a narrowing EBITDA loss despite operational headwinds and strategic restructuring in China.

Carnegie Clean Energy reported a $2.33 million net loss for FY2025 but made significant strides in commercialising its wave energy technologies, supported by new loans and a US subsidiary launch.

Regis Healthcare reported robust FY25 financial results, driven by increased occupancy, strategic acquisitions, and a strong balance sheet, positioning itself well ahead of the new Aged Care Act reforms.

Galan Lithium has cleared all hurdles for a $20 million placement to Clean Elements Fund, unlocking funding to complete Phase 1 of its Hombre Muerto West lithium project with production slated for early 2026.

Regis Healthcare has reported a robust FY25 financial performance, marked by significant profit growth and strategic acquisitions, positioning itself for ambitious expansion in Australia’s aged care sector.